You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 21, November 24, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular System, Other
 •Cardiovascular System
 •Randomized Controlled Trial
 •Prognosis/ Outcomes
 •Drug Therapy
 •Drug Therapy, Other
 •Endocrine Diseases
 •Diabetes Mellitus
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Randomized Trial of the Effect of Community Pharmacist and Nurse Care on Improving Blood Pressure Management in Patients With Diabetes Mellitus

Study of Cardiovascular Risk Intervention by Pharmacists–Hypertension (SCRIP-HTN)

Donna L. McLean, MN, RN NP; Finlay A. McAlister, MD, MSc, FRCPC; Jeffery A. Johnson, BSP, PhD; Kathryn M. King, RN, PhD; Mark J. Makowsky, BSP, PharmD; Charlotte A. Jones, PhD, MD, FRCPC; Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC; for the SCRIP-HTN Investigators

Arch Intern Med. 2008;168(21):2355-2361.

Background  Blood pressure (BP) control in patients with diabetes mellitus is difficult to achieve and current patterns are suboptimal. Given increasing problems with access to primary care physicians, community pharmacists and nurses are well positioned to identify and observe these patients. This study aimed to determine the efficacy of a community-based multidisciplinary intervention on BP control in patients with diabetes mellitus.

Methods  We performed a randomized controlled trial in 14 community pharmacies in Edmonton, Alberta, Canada, of patients with diabetes who had BPs higher than 130/80 mm Hg on 2 consecutive visits 2 weeks apart. Care from a pharmacist and nurse team included a wallet card with recorded BP measures, cardiovascular risk reduction education and counseling, a hypertension education pamphlet, referral to the patient's primary care physician for further assessment or management, a 1-page local opinion leader–endorsed evidence summary sent to the physician reinforcing the guideline recommendations for the treatment of hypertension and diabetes, and 4 follow-up visits throughout 6 months. Control-arm patients received a BP wallet card, a pamphlet on diabetes, general diabetes advice, and usual care by their physician. The primary outcome measure was the difference in change in systolic BP between the 2 groups at 6 months.

Results  A total of 227 eligible patients were randomized to intervention and control arms between May 5, 2005, and September 1, 2006. The mean (SD) patient age was 64.9 (12.1) years, 59.9% were male, and the mean (SD) baseline systolic/diastolic BP was 141.2 (13.9)/77.3 (8.9) mm Hg at baseline. The intervention group had an adjusted mean (SE) greater reduction in systolic BP at 6 months of 5.6 (2.1) mm Hg compared with controls (P = .008). In the subgroup of patients with a systolic BP greater than 160 mm Hg at baseline, BP was reduced by an adjusted mean (SE) of 24.1 (1.9) mm Hg more in intervention patients than in controls (P < .001).

Conclusion  Even in patients who have diabetes and hypertension that are relatively well controlled, a pharmacist and nurse team–based intervention resulted in a clinically important improvement in BP.

Trial Registration  clinicaltrials.gov Identifier: NCT00374270


Author Affiliations: Department of Medicine, Faculty of Medicine (Ms McLean and Drs McAlister and Tsuyuki), School of Public Health (Drs McAlister, Johnson, and Tsuyuki), and Faculty of Pharmacy and Pharmaceutical Sciences (Drs Makowsky and Tsuyuki), University of Alberta, Edmonton; and Institute of Health Economics (Drs McAlister, Johnson, and Tsuyuki) and Departments of Community Health Sciences (Drs King and Jones) and Medicine (Dr Jones), Faculty of Medicine, and Faculty of Nursing (Dr King), University of Calgary, Calgary, Alberta, Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

In This Issue of Archives of Internal Medicine
Arch Intern Med. 2008;168(21):2300.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Potency of Team-Based Care Interventions for Hypertension: A Meta-analysis
Carter et al.
Arch Intern Med 2009;169:1748-1755.
ABSTRACT | FULL TEXT  

Improving Diabetes Care: The Model for Health Care Reform
Kahn and Anderson
Diabetes Care 2009;32:1115-1118.
FULL TEXT  

A 41-Year-Old African American Man With Poorly Controlled Hypertension: Review of Patient and Physician Factors Related to Hypertension Treatment Adherence
Cooper
JAMA 2009;301:1260-1272.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.